Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management

• Published in: Medical sciences (Basel) Vol. 7; no. 12; p. 109
• Main Authors: Green, Travis P, Saavedra-Belaunde, Jose, Wang, Run
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10-12-2019; MDPI
• Subjects: Antidepressants; Behavior modification; Cancer therapies; Etiology; Orgasm; Patient satisfaction; Penis; Prostate cancer; Radiation therapy; Review; Serotonin; United States > US; prostate cancer; premature ejaculation; ejaculatory dysfunction; orgasm; painful ejaculation; anejaculation; climacturia; dysorgasmia
• ISSN: 2076-3271; 2076-3271
• DOI: 10.3390/medsci7120109

The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. This review provides an overview of prevalence and management options to deal with orgasmic dysfunction. A Medline Pubmed search was used to identify articles relating to these problems. We found that orgasmic dysfunction has a very large impact on patients' lives following prostate cancer treatment and there are ways for physicians to treat it. Management of patients' sexual health should be focused not only on erectile dysfunction, but on orgasmic dysfunction as well in order to ensure a healthy sexual life for patients and their partners.